|
|
社区获得性肺炎的诊治现状 |
黄文杰 |
南部战区总医院呼吸内科,广东 广州 510000 |
|
[1] World Health Organization. The top 10 causes of death. 2017. http://www.who.int/mediacenter/factsheets/fs310/en/. [2] Jain S, Self WH, Wunderic RG,et al. CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among US adults[J].N Engl J Med,2015,373(5): 415-427. [3] Claessens YE, Debray MP, Tubach F, et al. Early chest computed tomography scan to assist diagnosis and guidetreatment decision for suspected community-acquired pneumonia[J].Am J Respir Crit Care Med,2015,192(8):974-982. [4] Wunderink RG, Waterer G. Advances in the causes and management of community-acquired pneumonia in adults[J].BMJ,2017,358:2471-2483. [5] World Health Organization: Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected:Interm Guidance,12 January 2020. [6] Maskell NA, Batt S,Hedley EL, et al. The bacteriology of pleural infection by genetic and standard methods and its mortality significance[J].Am J Respir Crit Care Med,2006.174(7):817-823. [7] Petel PE, Bernardo P, Fogarty C, et al. Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia[J].Clin Infect Dis,2008,46(8):1142-1151. [8] Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adult with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America[J].Am J Respir Crit Care Med,2019;200(7):e45-e47. [9] Shino Y, Ito R, Kobayashi D, et al. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia[J].Am J Respir Crit Care Med ,2013,188(8):985-995. [10] Musher DM, Roig IL, Cazares G, et al. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study[J].J Infect,2013,67(1):11-18. [11] Musher DM, Rueda AM, Kaka AS, et al. The association between pneumococcal pneumonia and acute cardiac events[J].Clin Infect Dis,2007,45(2):158-165. [12] Guertler C, Wirz B, Christ-Crain M, et al. Inflammatory responses predict long-term mortality risk in community-acquired pneumonia[J].Eur Respir J,2011,37(6):1439-1446. [13] Lim WS, Rodrigo C, Turner AM, et al. British Thoracic Society. British Thoracic Society community-acquired pneumonia care bundle: results of a national implementation project[J].Thorax,2016,71(3):288-290. [14] Torres A, Lee N, Cilloniz C, et al. Laboratory diagnosis of pneumonia in the molecular age[J].Eur Respir J,2016,48(6):1764-1778. |
[1] |
李国英, 陈良, 刘军. Meta分析评价热毒宁注射液联合抗生素治疗儿童社区获得性肺炎的疗效及安全性[J]. 医学临床研究, 2020, 37(3): 385-389. |
[2] |
张允健, 唐钰坡, 祝金平. 中性粒细胞淋巴细胞比值与老年社区获得性肺炎患者病情严重程度和预后的关系[J]. 医学临床研究, 2019, 36(9): 1829-1831. |
[3] |
王同德, 陈淼, 李凡民. 肺炎严重指数评分与社区获得性肺炎患者致病菌的相关性分析[J]. 医学临床研究, 2019, 36(11): 2208-2210. |
[4] |
温丽华,杨汉华,陈志丹,马廉. 深圳东部地区儿童社区获得性肺炎痰培养及药敏实验结果分析[J]. 医学临床研究, 2018, 35(1): 126-128. |
[5] |
庄志,朱灿宏,李蓉,林英. 血清降钙素原、乳酸和脑钠肽在老年社区获得性肺炎诊断和预后评估中的价值[J]. 医学临床研究, 2017, 34(5): 898-900. |
[6] |
陈翀. 不同细胞因子在重症肺炎诊断中的临床意义[J]. 医学临床研究, 2014, 31(6): 1169-1171. |
[7] |
双庆翠;邓玎玎;朱丹;周治平. 支气管肺泡灌洗联合胸腺肽α1治疗老年医院获得性吸入性肺炎的疗效[J]. 医学临床研究, 2013, 30(7): 1390-1392. |
[8] |
李慎晔;杨旭光;卫茜. 降钙素原在新生儿感染性肺炎早期诊断中的应用[J]. 医学临床研究, 2013, 30(10): 1962-1964. |
[9] |
段效军;陈艳萍. 改良法防污染毛刷在小儿难治性肺炎中应用价值的探讨[J]. 医学临床研究, 2013, 30(1): 77-79. |
[10] |
李其杰;黎开宇;张海冰. 肺泡灌洗治疗高血压脑出血并发肺感染的临床疗效观察[J]. 医学临床研究, 2011, 28(12): 2293-2294. |
[11] |
李春华. 改良超声雾化吸入方法治疗小儿支气管肺炎的护理[J]. 医学临床研究, 2009, 26(1): 171-172. |
[12] |
朱华臣;钟发平;杨泽刚;邓志明;黄海;黄文胜. 肾移植术后重症肺炎诊治体会[J]. 医学临床研究, 2008, 25(5): 895-897. |
[13] |
王云华;侯伟伟. 慢性球形肺炎及其影像学诊断[J]. 医学临床研究, 2007, 24(11): 1825-1828. |
[14] |
王锡山;柳新权;徐延德. 床旁纤支镜肺泡灌洗治疗重型颅脑损伤并肺炎30例[J]. 医学临床研究, 2004, 21(6): 678-679. |
[15] |
邓跃林;唐昭喜. 发热门诊如何科学排查"SARS"的探讨[J]. 医学临床研究, 2004, 21(4): 433-436. |
|
|
|
|